Marta Alonso Hearn-rekin lankidetzan egindako argitalpenak (10)

2022

  1. Use of ATP-Binding Cassette Subfamily A Member 13 (ABCA13) for Sensitive Detection of Focal Pathological Forms of Subclinical Bovine Paratuberculosis

    Frontiers in Veterinary Science, Vol. 9

2021

  1. Bovine intelectin 2 expression as a biomarker of paratuberculosis disease progression

    Animals, Vol. 11, Núm. 5

  2. Control de la paratuberculosis bovina. Identificación y validación de biomarcadores de detección precoz de la enfermedad

    MG Mundo ganadero, Año 32, Núm. 298, pp. 28-33

  3. Control de la paratuberculosis bovina: nuevos métodos de diagnóstico basados en la detección de biomarcadores bovinos

    Tecnología agroalimentaria: Boletín informativo del SERIDA, Núm. 24, pp. 22-32

2020

  1. Detection of latent forms of Mycobacterium avium subsp. paratuberculosis infection using host biomarker-based ELISAs greatly improves paratuberculosis diagnostic sensitivity

    PLoS ONE, Vol. 15, Núm. 9 September 2020

2019

  1. RNA-Seq analysis of ileocecal valve and peripheral blood from Holstein cattle infected with Mycobacterium avium subsp. paratuberculosis revealed dysregulation of the CXCL8/IL8 signaling pathway

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. Association between combinations of genetic polymorphisms and epidemiopathogenic forms of bovine paratuberculosis

    Heliyon, Vol. 4, Núm. 2

2014

  1. Latent infections are the most frequent form of paratuberculosis in slaughtered Friesian cattle

    Spanish journal of agricultural research, Vol. 12, Núm. 4, pp. 1049-1060

  2. Mycobacterium Avium subsp. Paratuberculosis isolates induce in Vitro granuloma formation and show successful survival phenotype, common anti-inflammatory and antiapoptotic responses within ovine macrophages regardless of genotype or host of origin

    PLoS ONE, Vol. 9, Núm. 8

  3. Sensitive and specific enzyme-linked immunosorbent assay for detecting serum antibodies against Mycobacterium avium subsp. paratuberculosis in fallow deer

    Clinical and Vaccine Immunology, Vol. 21, Núm. 8, pp. 1077-1085